1. Robbins, K.C.,The plasminogen-plasmin enzyme system, In Colman, R.W., Hirsh, J., Marder, V.J. and Salzman, E.W. (Eds.) Hemostasis and Thrombosis, 2nd ed., J.B. Lippincott Company, Philadelphia, PA, U.S.A., 1987, pp. 340–357.
2. Schmaier, A.H., Silverberg, M., Kaplan, A.P. and Colman, R.W.,Contact activation and its abnormalities, In Colman, R.W., Hirsh, J., Marder, V.J. and Salzman, E.W. (Eds.) Hemostasis and Thrombosis, 2nd ed., J.B. Lippincott Company, Philadelphia, PA, U.S.A., 1987, pp. 18–38.
3. Royston, D., Bidstrup, B.P., Taylor, K.M. and Sapsford, R.N.,Effect of aprotinin on need for blood transfusion after repeat open-heart surgery, Lancet 2, (1987) 1289–1291.
4. Bidstrup, B.P., Royston, D., Sapsford, R.N. and Taylor, K.M.,Reduction in blood loss and blood use after cardiopulmonary bypass high dose aprotinin (trasylol), J. Thorac. Cardiovasc. Surg., 97 (1989) 364–372.
5. Royston, D.,Aprotinin therapy, Br. J. Anaesth., 73 (1994) 734–737.